TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines Post author:Sam Post published:August 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Dicerna Could Pocket $201M in NASH R&D Deal With Boehringer Ingelheim November 1, 2017 Zynerba Release: Company Announces Proposed Public Offering Of Common Stock January 18, 2017 FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017
FDA Advisory Committee Recommends Approval Of Pfizer???s Proposed Biosimilar To Epogen/Procrit Across All Indications May 25, 2017